Main Page Article Search E-Lerts™ Newsletter: Current E-Lerts™ Newsletter Archives E-Lerts™ Newsletter Recipes Archives Defeat Diabetes® E-Lerts™ Newsletter Subscribe Defeat Diabetes ® News by Daniel H. Rasolt Books You Can Use™ Subscribe to Defeat Diabetes Foundation Mailings
About Diabetes Body Care Children Complications Defeat Diabetes Foundation Drugs    » ACE Inhibitor    » Actos    » Alternative Medicine    » Aspirin    » Avandia    » Byetta    » Drugs    » Exenatide    » Glargine    » Glucophage    » Insulin    » Januvia    » Lantus    » Liraglutide    » Metformin    » Recall    » Research    » Rosiglitazone    » Self-Management    » Statins    » Sulfonylureas    » Victoza Elderly E-Lerts™ Governments & Organizations Health & Fitness Insulin MADDCAP™ Mr. Diabetes® Nutrition Obesity Other Diseases Pregnancy Research Risks Self-Management Supplements Type 1 Warning Signs

 

 

 

     

Drugs

Search our News Articles Archives for diabetes and health news. Search by word or phrase.  The latest article will appear first.

Search For:  

Search in all categories / subcategories
Search in current category / subcategory

TZD Patients Are 50% More Likely to Develop Bone Fractures Posted: Sunday, March 07, 2010

A Henry Ford Hospital study finds women with Type 2 diabetes who take a commonly prescribed class of medications called TZD's to treat insulin resistance may be at a higher risk for developing bone fractures within 1 year of taking the medication.

Coffee Drinkers Have Lower Stroke Risk Posted: Sunday, March 07, 2010

Drinking just one cup of coffee a day -- either regular or decaffeinated -- was associated with a 30% reduced risk of stroke, a large, prospective study showed.

Different Oral Antidiabetics Associated with Different Adverse Outcomes? Posted: Sunday, March 07, 2010

Risk of cardiovascular disease and all-cause mortality among patients with Type 2 diabetes prescribed oral antidiabetes drugs: retrospective cohort study using UK general practice research database.

FDA Reviewers Urge Pulling Rosiglitazone Posted: Sunday, February 28, 2010

Two FDA reviewers have recommended that the diabetes drug rosiglitazone (Avandia) be pulled from the market because of its link to major cardiac events.

Pramlintide + Metreleptin Combo Moving Forward for Treatment of Obesity Posted: Sunday, February 28, 2010

Amylin and Takeda announce decision to advance development of pramlintide/metreleptin combination treatment for obesity.

Small Increase in Diabetes Risk in Statin Patients Posted: Sunday, February 28, 2010

For many, benefits of lowering cholesterol outweigh drugs' downsides, researchers say.

Chocolate Linked to Lower Stroke and Stroke Mortality Risk Posted: Sunday, February 28, 2010

A new systematic review suggests higher chocolate consumption may be associated with a lower risk for incident stroke and stroke-related mortality.

Study Finds Insulin Regulates Beta Cell Function in Healthy Humans Posted: Sunday, February 28, 2010

Finding by Joslin scientists may aid in understanding how insulin production eventually goes wrong in Type 2 diabetes.

Lasting Benefit Seen for Lifestyle Changes, Metformin in Diabetes Posted: Sunday, February 28, 2010

For people at risk for Type 2 diabetes, a combination of diet, exercise and, to a lesser extent, treatment with metformin can help keep the disease at bay for 10 years, researchers said.

LifeScan Recalls Specific Lots of Consumer and Professional OneTouch® SureStep® Test Strips Due To Inaccurate Readings at High Levels Posted: Friday, February 26, 2010

LifeScan, Inc. is conducting a voluntary recall in the United States of eight lots of OneTouch® SureStep® Test Strips, used by people with diabetes to measure their blood glucose levels at home. The test strips are being recalled because they may provide falsely low glucose results when the glucose level is higher than 400 mg/dL.

 

 

 

 

 

 Costa Rica Travel Corp. will donate a portion of the proceeds to and is a sponsor of Defeat Diabetes Foundation.